Stock PTGX PROTAGONIST THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 12:47:28 2024-12-02 EST 		5-day change 1st Jan Change
42.85 USD -2.17% Intraday chart for Protagonist Therapeutics, Inc. -5.80% +87.05%
11-29 Protagonist Therapeutics Insider Sold Shares Worth $4,680,749, According to a Recent SEC Filing MT
11-29 Protagonist Therapeutics Insider Sold Shares Worth $5,635,430, According to a Recent SEC Filing MT

MarketScreener Strategies

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. News Protagonist Therapeutics, Inc.
  5. MarketScreener Strategies
Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition